9INHT - Overview: Factor IX Inhibitor Profile Technical Interpretation
Technical interpretation of inhibitor to factor IX testing for patients with hemophilia B
ROMA2 - Overview: Risk Score, if Postmenopausal, Serum
Calculating risk assessment for finding an ovarian malignancy during surgery in postmenopausal women who present with an adnexal mass
7INHT - Overview: Factor VII Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor VII testing
5INHT - Overview: Factor V Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor V testing
8AINH - Overview: Factor VIII Inhibitor Profile, Professional Interpretation
Interpretation for the detection of the presence and titer of a specific factor inhibitor directed against coagulation factor VIII
5AINH - Overview: Factor V Inhibitor Profile, Professional Interpretation
Interpretation of testing for factor V inhibitors
10INT - Overview: Factor X Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor X testing
FFTRO - Overview: Trofile DNA Co-Receptor Tropism Assay
Detect HIV-1 coreceptor tropism; determine eligibility for CCR5 antagonist therapy such as Selzentry™ (maraviroc).
Interpretation of testing performed as part of a profile to evaluate laboratory evidence of disseminated intravascular coagulation
ROMA1 - Overview: Risk Score, if Premenopausal, Serum
Calculating risk assessment for finding an ovarian malignancy during surgery in premenopausal women who present with an adnexal mass
FHEP2 - Overview: Heparin Cofactor II
Assessment of thrombotic risk associated with heparin cofactor II levels.
Increased levels of neopterin are found during impaired renal function and viral infection in transplant patients. Elevated levels are also indicators for conditions related to impaired cellular immunity.
FMYO3 - Overview: MyoMarker 3 Profile
MyoMarker 3 Profile
ACRN - Overview: Acylcarnitines, Quantitative, Plasma
Diagnosis of fatty acid oxidation disorders and several organic acidurias using plasma specimens Evaluating treatment during follow-up of patients with fatty acid beta-oxidation disorders and several organic acidurias
ADMI - Overview: ADAMTS13 Interpretation
Technical interpretation of testing performed to assist in the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura
BHISI - Overview: Bone Histomorphometry, Consultant Interpretation, Slides Only
Identifying undetermined metabolic bone disease in submitted slide specimens Diagnosing renal osteodystrophy Diagnosing osteomalacia Diagnosing osteoporosis Diagnosing Paget disease Assessing the effects of therapy Identifying...
MYCON - Overview: Mycoplasma pneumoniae Antibody Interpretation
Interpretation for Mycoplasma pneumoniae screening results
AADAM - Overview: ADAMTS13 Profile Interpretation
Technical interpretation of a profile to assist with the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura including inhibitor studies
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
CHAGI - Overview: Trypanosoma cruzi, Technical Interpretation
Diagnosis of chronic Trypanosoma cruzi infection (Chagas disease)
Interpretation for the evaluation of stiff-person spectrum disorders, including the classical or focal forms, such as stiff-limb or stiff-trunk, and progressive encephalomyelitis with rigidity and myoclonus, using spinal fluid specimens
Interpretation for the evaluation of stiff-person spectrum disorders including the classical or focal forms, such as stiff-limb or stiff-trunk, and progressive encephalomyelitis with rigidity and myoclonus, using serum specimens
WNVSI - Overview: West Nile Serum Interpretation
Interpretation of testing for a laboratory diagnosis of infection with West Nile virus
MALP - Overview: Malabsorption Evaluation Panel, Feces
Evaluation of patients with suspected malabsorption, as suggested by chronic diarrhea, unexplained weight loss, or nutritional deficiencies Differentiation between causes of malabsorption, specifically inflammatory conditions, pancreatic...
Since the pandemic hit, she's spent a great deal of time vetting antibody tests and has set up a COVID-19 testing program at Mayo Clinic....
Staffing to Workload in Phlebotomy Areas: Off-Site Operational Needs - Insights
discusses staffing to workload in phlebotomy areas with a focus on off-site operational needs, including paid time off and unpaid time off....
practices from the program, Mayo Medical Laboratories collaborated with National Decision Support Company (NDSC) to combine Mayo’s clinical knowledge with NDSC’s industry-leading expertise in electronic...
Laboratory and pathology research roundup: August 30 - Insights
This week's research roundup features: Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis...
Visit Mayo Clinic Laboratories at the APA Annual Meeting - Insights
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing...